Cargando…
Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis
Autores principales: | Anand, Pria, Mukerji, Shibani S., Thon, Jesse, Gunaratne, Shauna, Cho, Tracey A., Venna, Nagagopal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745724/ https://www.ncbi.nlm.nih.gov/pubmed/31454762 http://dx.doi.org/10.1212/NXI.0000000000000606 |
Ejemplares similares
-
1406. Steroid-Sparing Agents to Control Inflammation in Complicated Neurocysticercosis: Three Cases
por: Anand, Pria, et al.
Publicado: (2019) -
Immunotherapy-responsive dorsal column myelopathy in a patient with asymptomatic celiac disease
por: Bradshaw, Michael J., et al.
Publicado: (2018) -
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent
por: Thebault, Simon, et al.
Publicado: (2022) -
Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study
por: Anand, Pria, et al.
Publicado: (2019) -
Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis
por: Nash, Theodore E., et al.
Publicado: (2019)